Academic investigators’ interest in promoting specified clinical trials : Questionnaire survey before and after implementation of the Clinical Trial Act
Masayuki Chuma(Nihon University), Hiroaki Yanagawa(Tokushima University Hospital), Hiroshi Nokihara(Tokushima University Hospital), Yoshito Zamami(Tokushima University Hospital), Yasutaka Sato(Tokushima University Hospital), Takahiro Niimura(Tokushima University), Chikako Kane(Tokushima University Hospital), Mitsuhiro Goda(Okayama University), Keisuke Ishizawa(Tokushima University Hospital), Satoshi Sakaguchi(Tokushima University Hospital), Kenta Yagi(Tokushima University Hospital), Kenshi Takechi(Matsuyama University)
Cited by 2
Related Papers
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134
Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study
|Clinical Therapeutics|2018|99
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
|Annals of Oncology|2017|97
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
|Biological and Pharmaceutical Bulletin|2008|88